Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Synaptic plasticity is an important mechanism that underlies learning and cognition. Protein phosphorylation by kinases and dephosphorylation by phosphatases play critical roles in the activity-dependent alteration of synaptic plasticity. In this study, we report that
Wip1
, a protein phosphatase, is essential for long-term potentiation (LTP) and long-term depression (LTD) processes.
Wip1
-deletion suppresses LTP and enhances LTD in the hippocampus CA1 area.
Wip1
deficiency-induced aberrant elevation of
CaMKII
T286/287 and T305 phosphorylation underlies these dysfunctions. Moreover, we showed that
Wip1
modulates
CaMKII
dephosphorylation.
Wip1
(-/-) mice exhibit abnormal GluR1 membrane expression, which could be reversed by the application of a
CaMKII
inhibitor, indicating that
Wip1
/
CaMKII
signaling is crucial for synaptic plasticity. Together, our results demonstrate that
Wip1
phosphatase plays a vital role in regulating hippocampal synaptic plasticity by modulating the phosphorylation of
CaMKII
.
...
PMID:Wip1 phosphatase modulates both long-term potentiation and long-term depression through the dephosphorylation of CaMKII. 2715 69